Ambu A/S (AMBBY)
OTC Markets OTCPK · USD · Healthcare · Medical Devices
$11.64 (+0.00%) as of
Key statistics
- Market cap
- 3.03B
- P/E (TTM)
- 38.80
- EPS (TTM)
- 0.30
- Dividend yield
- 0.55%
- 52-week range
- 8.55 – 16.31
- Beta
- 1.38
- Revenue (TTM)
- 6.24B
- Profit margin
- 8.18%
- Volume
- 60.00
About Ambu A/S
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also provides airway management and anaesthesia products, which include double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers emergency care and training products, such as extrication collars and ALS and BLS training manikins, as well as mobile workstations, IOMs, and patient monitoring and diagnostics devices. Further, the company manufactures video capture solutions for OEMs in medical and defense imaging applications. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Ballerup, Denmark
- Employees
- 5,200
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.